fendiline has been researched along with Angina Pectoris, Variant in 1 studies
Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.
Angina Pectoris, Variant: A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kababgi, MD | 1 |
| Schneider, KW | 1 |
| Deeg, P | 1 |
1 other study available for fendiline and Angina Pectoris, Variant
| Article | Year |
|---|---|
[Effect of the calcium antagonist fendiline on digitalis-induced ischemic reactions in the ECG].
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Digitalis Glycosides; Electrocardiography; Female; | 1980 |